Price to Book Value Chart

View Price to Book Value for AARD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2025. Start Trial.
Date Value
September 04, 2026 1.574
September 03, 2026 1.676
September 02, 2026 1.741
September 01, 2026 1.732
August 31, 2026 1.785
August 28, 2026 1.694
August 27, 2026 1.937
August 26, 2026 1.992
August 25, 2026 2.121
August 24, 2026 2.013
August 21, 2026 1.995
August 20, 2026 1.723
August 19, 2026 1.975
August 18, 2026 1.798
August 17, 2026 1.972
August 14, 2026 1.914
August 13, 2026 1.875
August 12, 2026 1.922
August 11, 2026 2.104
August 10, 2026 2.212
August 07, 2026 2.311
August 06, 2026 2.136
August 05, 2026 2.200
August 04, 2026 2.115
August 03, 2026 2.072
Date Value
July 31, 2026 1.931
July 30, 2026 1.872
July 29, 2026 1.556
July 28, 2026 1.878
July 27, 2026 1.957
July 24, 2026 1.849
July 23, 2026 1.870
July 22, 2026 1.896
July 21, 2026 1.779
July 20, 2026 1.618
July 17, 2026 1.714
July 16, 2026 1.852
July 15, 2026 1.952
July 14, 2026 1.832
July 13, 2026 1.744
July 10, 2026 2.224
July 09, 2026 1.463
July 08, 2026 1.545
July 07, 2026 1.592
July 06, 2026 1.753
July 02, 2026 1.668
July 01, 2026 1.644
June 30, 2026 1.685
June 29, 2026 1.299
June 26, 2026 1.201

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.740
Corcept Therapeutics, Inc. 17.07
Veru, Inc. 1.586
Johnson & Johnson 7.800
Eli Lilly & Co. 31.94

Price to Book Value Related Metrics

PEG Ratio -0.0188
Price 5.38
Earnings Yield -59.58%
Market Cap 117.74M
PEGY Ratio -0.0188